BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27079681)

  • 1. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.
    Marras C; Lang A; van de Warrenburg BP; Sue CM; Tabrizi SJ; Bertram L; Mercimek-Mahmutoglu S; Ebrahimi-Fakhari D; Warner TT; Durr A; Assmann B; Lohmann K; Kostic V; Klein C
    Mov Disord; 2016 Apr; 31(4):436-57. PubMed ID: 27079681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.
    Lange LM; Gonzalez-Latapi P; Rajalingam R; Tijssen MAJ; Ebrahimi-Fakhari D; Gabbert C; Ganos C; Ghosh R; Kumar KR; Lang AE; Rossi M; van der Veen S; van de Warrenburg B; Warner T; Lohmann K; Klein C; Marras C;
    Mov Disord; 2022 May; 37(5):905-935. PubMed ID: 35481685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.
    Marras C; Lohmann K; Lang A; Klein C
    Neurology; 2012 Mar; 78(13):1016-24. PubMed ID: 22454269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.
    van der Veen S; Zutt R; Klein C; Marras C; Berkovic SF; Caviness JN; Shibasaki H; de Koning TJ; Tijssen MAJ
    Mov Disord; 2019 Nov; 34(11):1602-1613. PubMed ID: 31584223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.
    Marras C; Lang A; van de Warrenburg BP; Sue CM; Tabrizi SJ; Bertram L; Mercimek-Mahmutoglu S; Ebrahimi-Fakhari D; Warner TT; Durr A; Assmann B; Lohmann K; Kostic V; Klein C
    Mov Disord; 2017 May; 32(5):724-725. PubMed ID: 28513081
    [No Abstract]   [Full Text] [Related]  

  • 6. The genetic nomenclature of recessive cerebellar ataxias.
    Rossi M; Anheim M; Durr A; Klein C; Koenig M; Synofzik M; Marras C; van de Warrenburg BP;
    Mov Disord; 2018 Jul; 33(7):1056-1076. PubMed ID: 29756227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study.
    Dale RC; Grattan-Smith P; Nicholson M; Peters GB
    Dev Med Child Neurol; 2012 Jul; 54(7):618-23. PubMed ID: 22515636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
    Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
    JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of pediatric movement disorders.
    Paulson HL; Paulson GW
    Semin Pediatr Neurol; 2003 Mar; 10(1):88-95. PubMed ID: 12785752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic considerations in movement disorders.
    Wszolek ZK; Pfeiffer RF
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):324-30. PubMed ID: 1623259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
    Mirelman A; Saunders-Pullman R; Alcalay RN; Shustak S; Thaler A; Gurevich T; Raymond D; Mejia-Santana H; Orbe Reilly M; Ozelius L; Clark L; Gana-Weisz M; Bar-Shira A; Orr-Utreger A; Bressman SB; Marder K; Giladi N;
    Mov Disord; 2018 Jul; 33(6):966-973. PubMed ID: 29603409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Movement disorders in childhood: classification and genetic update].
    Roubertie A; Rivier F; Tuffery-Giraud S; Humbertclaude V; Claustres M; Cheminal R; Echenne B
    Arch Pediatr; 2003 Nov; 10(11):994-1002. PubMed ID: 14613695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
    Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA
    Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum.
    Schreglmann SR; Riederer F; Galovic M; Ganos C; Kägi G; Waldvogel D; Jaunmuktane Z; Schaller A; Hidding U; Krasemann E; Michels L; Baumann CR; Bhatia K; Jung HH
    Mov Disord; 2018 Jan; 33(1):146-155. PubMed ID: 28901595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal movement disorders: Recent advances and proposal of a classification system.
    Zhang XJ; Xu ZY; Wu YC; Tan EK
    Parkinsonism Relat Disord; 2019 Feb; 59():131-139. PubMed ID: 30902529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.
    Khalil H; Chahine LM; Siddiqui J; Salari M; El-Jaafary S; Aldaajani Z; Abu Al-Melh M; Mohammad TM; Abu Snineh M; Syed NA; Bhatt M; Habib MA; Habahbeh M; Tabbal SD; Jeon B; Bajwa JA
    J Parkinsons Dis; 2020; 10(2):729-741. PubMed ID: 32176653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders and mitochondrial dysfunction.
    Hanna MG; Bhatia KP
    Curr Opin Neurol; 1997 Aug; 10(4):351-6. PubMed ID: 9266161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited movement disorders.
    Sharma N; Standaert DG
    Neurol Clin; 2002 Aug; 20(3):759-78, vii. PubMed ID: 12432829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide barriers to genetic testing for movement disorders.
    Gatto EM; Walker RH; Gonzalez C; Cesarini M; Cossu G; Stephen CD; Balint B; Rodríguez-Violante M; Jankovic J; Morgante F; Jinnah HA;
    Eur J Neurol; 2021 Jun; 28(6):1901-1909. PubMed ID: 33730413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.